Today, a federal jury in Illinois ordered pharmaceutical company AbbVie to pay $150 million in punitive damages to a plaintiff who alleged that his heart attack was the result of using its testosterone-boosting product, AndroGel. Although the jury found that AbbVie...

In just a few months juries around the country will begin hearing cases against drug maker AbbVie about the dangers associated with their testosterone treatments. According to those lawsuits the testosterone treatment AndroGel has been linked to a big increase in the...

The U.S. Food and Drug Administration (FDA) issued a Safety Announcement on March 3 warning the public that testosterone products are not approved for use in treating low testosterone as a result of aging. The warning addresses increased prescription of testosterone...

For many men, the act of growing older can be a troubling time in their lives. They experience lethargy, lowered libido, less mental acuity. It’s part of the process of aging. Pharmaceutical companies, however, have taken issue with mother nature’s course and decided...

For men, aging is a delicate thing. Many men have some concept of their identity tied up in their physicality. With age comes change though, and for many men this means diminishing physical capacity. But fret not ye aging men! Big pharma has come up with a name for...

The U.S. Food and Drug Administration (FDA) announced that it will strengthen the label on testosterone treatments to warn about the risks of developing blood clots. Testosterone treatments have been associated with a number of cardiological problems among patients...

Testosterone products, e.g. AndroGel, Androderm, and Axiron, are under fire for their underreported propensity to cause heart attacks and strokes in individuals. Public Citizen announced yesterday that they have filed a petition to the U.S. Food and Drug...